SUBSCRIBE
SUBSCRIBE

BigHat Biosciences

NEWS
Pictured: scientist working on machine learning mo
10 Biopharma Companies Hiring AI/ML Talent Now
To help with your job search, here are 10 biopharma companies hiring for Artificial Intelligence and Machine Learning (AI/ML) roles now.
April 17, 2023
 · 
3 min read
 · 
Rosemary Scott
Image courtesy of Getty Images
Business
Merck to Leverage BigHat’s AI Platform in 3 Drug Discovery Programs
BigHat Biosciences will team up with Merck to design candidates for three drug discovery programs backed by the company’s proprietary AI technology platform.
November 29, 2022
 · 
2 min read
 · 
Alex Keown
BigHat BioScience’s founders – CEO Mark DePristo a
Business
BigHat Plans to Take Antibody Engineering to a Whole New Level
BigHat is a Bay-area startup that’s reimagining antibody development with the help of AI and ML (machine learning) technologies through data-driven discovery.
February 9, 2021
 · 
5 min read
 · 
Kate Goodwin
JOBS
IN THE PRESS
Business
BigHat Biosciences Enters Into Strategic Collaboration to Leverage Machine Learning in Antibody Discovery & Design
April 24, 2024
 · 
2 min read
Business
AbbVie and BigHat Biosciences Announce Research Collaboration to Leverage Artificial Intelligence and Machine Learning to Discover Next-Generation Therapeutic Antibodies
December 5, 2023
 · 
4 min read
Business
BigHat Biosciences Announces Research Collaboration with Merck
November 29, 2022
 · 
2 min read
Biotech Bay
BigHat Biosciences Raises $75 Million in Series B Funding to Design Safer, More Effective Antibodies
July 20, 2022
 · 
7 min read
Business
BigHat Biosciences Appoints Rob Chess, Serial Entrepreneur, to its Board of Directors
May 11, 2022
 · 
2 min read
Deals
BigHat Biosciences Completes Its Acquisition of Frugi Biotechnology
March 28, 2022
 · 
2 min read
Business
BigHat Biosciences Completes First Stage of Research Collaboration with Amgen
January 11, 2022
 · 
3 min read
Biotech Bay
BigHat Biosciences Raises $19 Million in Series A Funding to Advance Antibody Design and Development for Safer, More Effective Treatments
February 10, 2021
 · 
5 min read